These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 8727344)
21. [Biological parameters of the efficiency of retinoic acid in acute leukemia]. Chomienne C; Cornic M; Castaigne S; Lefebvre P; de Thé H; Dejean A; Degos L C R Seances Soc Biol Fil; 1991; 185(6):456-63. PubMed ID: 1822394 [TBL] [Abstract][Full Text] [Related]
22. All-trans retinoic acid as a single agent induces complete remission in a patient with acute leukemia of M2a subtype. Chen Z; Wang Y; Wang W; Gong J; Xue Y Chin Med J (Engl); 2002 Jan; 115(1):58-61. PubMed ID: 11930660 [TBL] [Abstract][Full Text] [Related]
23. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution. Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of poly(ADP-ribose) polymerase promotes cell cycle arrest and inhibits neutrophilic differentiation of NB4 acute promyelocytic leukemia cells. Bhatia M; Kirkland JB; Meckling-Gill KA Cell Growth Differ; 1996 Jan; 7(1):91-100. PubMed ID: 8788037 [TBL] [Abstract][Full Text] [Related]
25. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells. Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431 [TBL] [Abstract][Full Text] [Related]
27. Differentiation induction of human promyelocytic leukemia cells by acyclic retinoid (polyprenoic acid). Tsurumi H; Tojo A; Takahashi T; Ozawa K; Moriwaki H; Asano S; Muto Y Int J Hematol; 1993 Dec; 59(1):9-15. PubMed ID: 8161738 [TBL] [Abstract][Full Text] [Related]
28. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia. Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155 [TBL] [Abstract][Full Text] [Related]
29. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response. Grignani F; Gelmetti V; Fanelli M; Rogaia D; De Matteis S; Ferrara FF; Bonci D; Grignani F; Nervi C; Pelicci PG Oncogene; 1999 Nov; 18(46):6313-21. PubMed ID: 10597230 [TBL] [Abstract][Full Text] [Related]
30. [Co-operative study of all-trans retinoic acid as a differentiation induction therapy of acute promyelocytic leukemia]. Yamada O; Hatake K; Tanimoto M; Ishiyama T; Ohno R; Shirakawa S; Horiuchi A; Tomonaga M; Ohta K Gan To Kagaku Ryoho; 1994 Sep; 21(12):1981-9. PubMed ID: 8085849 [TBL] [Abstract][Full Text] [Related]
31. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells. Lehmann S; Paul C; Törmä H Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all-trans-retinoic acid]. Tsurugano S; Togawa A; Soda Y; Miwa A; Takaku F; Yuo A; Yamada K; Hirai H Rinsho Ketsueki; 1994 Jan; 35(1):36-41. PubMed ID: 8139100 [TBL] [Abstract][Full Text] [Related]
33. [Acute promyelocytic leukemia. The therapeutic advances]. de Lacerda JF; do Carmo JA; de Lacerda JM Acta Med Port; 1993 Oct; 6(10):473-80. PubMed ID: 8285119 [TBL] [Abstract][Full Text] [Related]
34. [The relation between expression of PML-RAR alpha gene and effects of ATRA on proliferation and differentiation of NB4 cells]. Yu W; Sun B; Chen Z Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):745-9. PubMed ID: 9772518 [TBL] [Abstract][Full Text] [Related]
35. [All-trans retinoic acid induced a complete remission in a case of refractory relapsed acute promyelocytic leukemia]. Takeuchi J; Miyajima T; Kawamura T; Sakuma J; Endo M; Iizuka Y; Nishinarita S; Horikoshi A; Ohshima T; Horie T Rinsho Ketsueki; 1992 Feb; 33(2):244-9. PubMed ID: 1635177 [TBL] [Abstract][Full Text] [Related]
36. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells. Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of semiquantitative reverse transcriptase-polymerase chain reaction assay of PML/retinoic acid receptor alpha mRNA and in vitro differentiation assay as prognostic prediction in acute promyelocytic leukemia treated with all-trans retinoic acid. Iwakiri R; Inokuchi K; Dan K; Wakabayashi I Nihon Ika Daigaku Zasshi; 1996 Aug; 63(4):259-67. PubMed ID: 8810554 [TBL] [Abstract][Full Text] [Related]
38. Targeting the PML/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells. Nason-Burchenal K; Takle G; Pace U; Flynn S; Allopenna J; Martin P; George ST; Goldberg AR; Dmitrovsky E Oncogene; 1998 Oct; 17(14):1759-68. PubMed ID: 9778041 [TBL] [Abstract][Full Text] [Related]
39. Retinoic acid in acute promyelocytic leukemia: the promise and the paradox. Clarkson B Cancer Cells; 1991 Jun; 3(6):211-20. PubMed ID: 1911035 [TBL] [Abstract][Full Text] [Related]